Msteller

The Pharmaceutical Printed Literature Association (PPLA) emphasizes how the FDA’s proposed digital-only format for Patient Medication Information (PMI) would worsen health disparities. Many low-income Americans lack access to digital resources, risking medication non-adherence and adverse effects. The bipartisan Patients’ Right to Know Their Medication Act (H.R. 1173) aims to preserve printed PMI for patient safety.

The Pharmaceutical Printed Literature Association (PPLA) warns about health risks of shifting Patient Medication Information (PMI) to digital format due to expiring broadband access program. Over 100,000 annual deaths result from medication non-adherence, posing risks for 42 million Americans without broadband. PPLA supports the Patients’ Right to Know Their Medication Act (H.R. 1173) to maintain printed PMI access.

A study by MLPS reveals proposed changes in patient medication information delivery could cost the EU up to €3.5 billion annually. The bipartisan Patients’ Right to Know Their Medication Act aims to protect access to printed PMI and has 14 bipartisan cosponsors. The Pharmaceutical Printed Literature Association advocates for patient safety and accessibility.

The Pharmaceutical Printed Literature Association (PPLA) hails Congresswoman Perez for supporting the bipartisan Patients’ Right to Know Their Medication Act, which aims to standardize medication information, reduce confusion, and improve patient adherence. The act is co-sponsored by several representatives and supported by the PPLA to ensure clear, accessible medication information for all Americans.

The Pharmaceutical Printed Literature Association (PPLA) praises Congresswoman Peltola for supporting the Patients’ Right to Know Their Medication Act, aiming to standardize medication information and reduce medication-related issues. The lack of standardization causes confusion and non-adherence, leading to adverse events and high costs. The bipartisan bill aims to improve patient safety and minimize risks.

The Centers for Medicare and Medicaid Services’ (CMS) decision to cease providing printed data to researchers is harmful! Virtual databases create barriers, delays, and disproportionally affect institutions with fewer technological resources. We urge CMS to reconsider its decision and prioritize research quality and accessibility. CMS’ efficacy depends on it.

The Pharmaceutical Printed Literature Association (PPLA) emphasized the vital role of printed Patient Medication Information (PMI) for patient safety in rural areas. They oppose proposals to shift PMI to digital-only formats, arguing that rural residents face unique challenges, like limited broadband access, which makes printed PMI crucial for safe medication management. They support the Patients’ Right to Know Their Medication Act (H.R. 1173) to ensure access to essential medication information.

Press Release : PPLA Washington, D.C. (January 29th, 2024) – A new report from Punchbowl News highlighted the worsening outlook for the Federal Communications Commission’s (FCC) Affordable Connectivity Program, underscoring…